Heart failure progression shares multiple molecular signaling pathways for cell growth, death, and survival with cancer biology, offering new biologically targeted therapeutic strategies.
Pathways for surrogate failing heart phenotypesChamber dilation: diverse cytoskeletal pathways.Changes in organ size, shape, and histological phenotype are central features of both tumorigenesis and heart failure.Chronic increases
Hoshijima et al. (Mon,) conducted a review in Heart failure. Heart failure progression shares multiple molecular signaling pathways for cell growth, death, and survival with cancer biology, offering new biologically targeted therapeutic strategies.